Skip to main content
Fig. 6 | Nanoscale Research Letters

Fig. 6

From: Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination

Fig. 6

Tumor volume of established H22 xenografts in ICR mice during therapy under different treatments. Mice were treated with different strategies on day 0 as shown in the figure: 3 mg/kg of free CDDP, free CDDP together with Tet (CDDP 3 mg/kg + Tet 7.2 mg/kg), and CDDP-Tet-loaded NPs (CDDP 3 mg/kg + Tet 7.2 mg/kg), respectively. Mean ± SD (n = 6) of each group was measured

Back to article page